Back to Search
Start Over
Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients.
- Source :
-
Blood [Blood] 2022 Jan 06; Vol. 139 (1), pp. 142-147. - Publication Year :
- 2022
- Subjects :
- Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized adverse effects
Antibodies, Monoclonal, Humanized therapeutic use
Antibodies, Neutralizing biosynthesis
Antibodies, Viral biosynthesis
Antigens, CD20 immunology
Antineoplastic Agents, Immunological adverse effects
Antineoplastic Agents, Immunological therapeutic use
Female
Humans
Immunity, Cellular
Immunocompromised Host
Male
Middle Aged
Multivariate Analysis
Rituximab adverse effects
Rituximab therapeutic use
Seroconversion
Young Adult
COVID-19 immunology
COVID-19 prevention & control
COVID-19 Vaccines administration & dosage
Lymphoma immunology
Lymphoma therapy
SARS-CoV-2 immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1528-0020
- Volume :
- 139
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Blood
- Publication Type :
- Report
- Accession number :
- 34669919
- Full Text :
- https://doi.org/10.1182/blood.2021013445